02392nam a2200421Ia 4500001001300000003000600013005001700019007001400036008004100050020001800091020001500109040006100124043001200185050002200197074001600219086002900235110017000264245024700434260008500681300002800766336002600794337002700820338003100847490002300878500003600901500002500937504004100962533009301003610007001096650004001166650004401206650003701250650003601287650005401323776027501377776025801652810006001910ocn476741961OCoLC20171113165655.0he bmb024bbca091210s2008    dcu     bb   f000 0 eng d  a9780160804953  a0160804957  aFPSbengcFPSdSLAdOCLCAdOCLCFdOCLCOdOCLCQdGPOdMvI  an-us---14aKF26b.A644 2007d  a1033-A (MF)0 aY 4.AP 6/2:S.HRG.110-2931 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.10aFood and Drug Administration's Critical Path Initiative :bhearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O.,c2008.  aiii, 42 pages ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v110-293  aShipping list no.: 2009-0307-M.  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.bWashington :cSupt. of Docs., U.S. G.P.O.,d2009.e1 microfiche : negative.10aUnited States.bFood and Drug AdministrationxRules and practice. 0aBiological productszUnited States. 0aPharmaceutical industryzUnited States. 0aDrug developmentzUnited States. 0aDrugsxResearchzUnited States. 0aPublic-private sector cooperationzUnited States.08iPrint version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.tFood and Drug Administration's Critical Path Initiativew(DLC) 2008377100w(OCoLC)21386563708iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.tFood and Drug Administration's Critical Path Initiativew(OCoLC)6475164921 aUnited States.bCongress.bSenate.tS. hrg. ;v110-293.